Padviram (Emtricitabine, Efavirenz, Tenofovir Disoproxil Succinate)

Emtricitabine, the active ingredient in Padviram, is a nucleoside reverse transcriptase inhibitor presented as a fixed-dose combination tablet for oral use. It treats HIV-1 infection in adults and adolescents. GNH USA supplies Padviram as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Padviram as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Padviram is a fixed‑dose combination antiretroviral medication that targets the HIV replication pathway.

- HIV-1 infection in treatment‑naïve adults: Improves viral suppression and CD4+ count when used with other antiretrovirals. - HIV-1 infection in adolesc ‑ aged 12 and above : Maint ​​   - HIV   

Common